Showing results (91-100 of 143) with videos related to

Sort By:
Pageof 15
RSC Advances|August 3, 2022
A validated LC-MS/MS analytical method for the quantification of pemigatinib: metabolic stability evaluation in human liver microsomesMohamed W Attwa, Ali S Abdelhameed, Nawaf A Alsaif, et al.
Royal Society Open Science|February 26, 2019
Identification of reactive intermediate formation and bioactivation pathways in Abemaciclib metabolism by LC-MS/MS: <i>in vitro</i> metabolic investigationAdnan A Kadi, Hany W Darwish, Hatem A Abuelizz, et al.
Molecules (Basel, Switzerland)|May 27, 2023
Investigation of Fenebrutinib Metabolism and Bioactivation Using MS<sup>3</sup> Methodology in Ion Trap LC/MSAishah M Alsibaee, Haya I Aljohar, Mohamed W Attwa, et al.
ACS Omega|July 5, 2022
<i>In Vitro</i> Identification of Potential Metabolites of Plinabulin (NPI 2358) in Hepatic Preparations Using Liquid Chromatography-Ion Trap Mass SpectrometryNasser S Al-Shakliah, Adnan A Kadi, Rashad Al-Salahi, et al.
Organic & Biomolecular Chemistry|August 3, 2017
Enzyme-instructed self-assembly with photo-responses for the photo-regulation of cancer cellsZhengquan Zhou, Xian Xie, Qikun Yi, et al.
Organic & Biomolecular Chemistry|February 22, 2017
A photo-degradable supramolecular hydrogel for selective delivery of microRNA into 3D-cultured cellsZhengquan Zhou, Qikun Yi, Tingting Xia, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 5, 2022
Estimation of zorifertinib metabolic stability in human liver microsomes using LC-MS/MSMohamed W Attwa, Nasser S Al-Shakliah, Haitham AlRabiah, et al.
RSC Advances|May 21, 2024
Ion Trap LC/MS reveals the generation of reactive intermediates in acalabrutinib metabolism: phase I metabolic profiling and bioactivation pathways elucidationAishah M Alsibaee, Haya I Aljohar, Mohamed W Attwa, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 4, 2023
Piperazine ring toxicity in three novel anti-breast cancer drugs: an in silico and in vitro metabolic bioactivation approach using olaparib as a case studyThamer A Alsubi, Mohamed W Attwa, Hany W Darwish, et al.
RSC Advances|May 6, 2022
Reactive intermediates in copanlisib metabolism identified by LC-MS/MS: phase I metabolic profilingHaitham AlRabiah, Adnan A Kadi, Mohamed W Attwa, et al.
Pageof 15